Clearmind Medicine Inc. (CMND) stock
CMNDNasdaqPharmaceutical PreparationsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Score 5/30
$3.45−0.73 (-17.52%)
Close on Nov 17, 2026Market cap $545.36KP/E –Yield –
Clearmind Medicine operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2023CQ1 2023 | Apr 30, 2023 | -$1.66M | – |
| Q2 FY2022CQ1 2022 | Apr 30, 2022 | -$2.22M | – |
See a number that looks wrong?